Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS

Treatment.com - Building the Smartest Artificial Intelligence (AI) System for Healthcare


VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- "AI has no greater purpose than improving the health of everyone," says CEO John Fraser.

Every day, one billion people turn to Google to inquire about their health concerns. Treatment.com saw the opportunity to provide more accurate results backed by powerful Artificial Intelligence (AI) technology. They created easy and supportive digital tools to help people make important decisions and improve their health. Cara, Treatment.com's AI health assistant, will support moms, dads, families and patients with trusted information about their health.

Treatment's AI is built and maintained by a global network of doctors, contributing their knowledge and expertise to a proprietary AI engine that's always getting smarter. Their doctors work 24/7 to build a world class global medical library, a resource for personalized, reliable health information. Their sophisticated AI engine is applicable to many sectors of healthcare including the consumer, physician, and, insurance and provider communities. This hyper-personalized approach to health care will provide better health insights that will have a profound impact on improving health outcomes.

"Working with leading North American medical schools has been transformative," said CEO John Fraser. "We have brought together the best doctors and engineers from around the world to teach Cara how to think like a doctor and provide a more accurate recommendation than any other digital tool out there."

About Treatment.com

Treatment.com is a disruptive healthcare technology startup that is harnessing the power of AI to help Canadians improve their health through personalized recommendations and insights. Based in Vancouver, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara. This summer, Cara will be empowering Canadians to take control of their health with the launch of an innovative mobile app powered by this exclusive AI engine.

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

For more information on Treatment.com please visit https://treatment.com.

Investor Contact: investors@treatment.com



These press releases may also interest you

at 21:15
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced its financial results and operational highlights for the first quarter...

at 21:08
Americans spend nearly twice as much for prescription medication compared to what residents of other countries pay. The comparison is with modern countries with good healthcare provisioning systems too, so the question becomes why are drugs so...

at 21:05
As the world joins together to fight the ongoing battle against the COVID-19 pandemic, Terumo Corporation (TSE: 4543) has announced that the Terumo Group companies will collectively donate USD 1 million in cash to support the COVID-19 Solidarity...

at 21:00
The allergy immunotherapies market is poised to grow by USD 713.56 million during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. Here is an Exclusive report talking about Market scenarios, Estimates, the impact of...

at 20:40
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology,...

at 20:30
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide...



News published on 21 april 2021 at 08:00 and distributed by: